A study of liposomal bupivacaine for ultrasound-guided suprabrachial plexus block at the lowest effective concentration in shoulder arthroscopic surgery

A study of liposomal bupivacaine for ultrasound-guided suprabrachial plexus block at the lowest effective concentration in shoulder arthroscopic surgery - Study of the lowest effective concentration of liposomes of bupivacaine

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400084500

Enrollment

Unknown

Registered

2024-05-17

Start date

2024-07-01

Completion date

Unknown

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff injury

Interventions

Test group:Liposomes of bupivacaine at different concentrations are used for ultrasound-guided suprabrachial plexus trunk block

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing elective shoulder arthroscopic surgery and anesthesia for suprabrachial plexus nerve block; (2) American society of anesthesiologists (ASA) grade I-II; (3) Age 18-70 years old, gender is not limited; (4) Body Mass Index (BMI): 18.5-30kg/m^2.

Exclusion criteria

Exclusion criteria: (1) Subject refuses to participate in the study; (2) History of local anesthetic allergy in the past; (3) pregnancy; (4) Mental nervous system, craniocerebral injury and other diseases resulting in inability to communicate and cooperate; (5) brachial plexus injury; (6) The skin at the puncture site is infected or damaged; (7) Coagulation dysfunction.

Design outcomes

Primary

Measure	Time frame
Bupivacaine liposomal MEC90;	—

Secondary

Measure	Time frame
Duration of block;Unilateral diaphragm paralysis (HDP) severity;Effect on muscle strength of the upper limbs;Postoperative pain assessment;Complications occur;	—

Countries

China

Contacts

Public ContactChen Yan

Zhuji People's Hospital of Zhejiang Province

1844786725@qq.com+86 136 0685 3009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026